Heron Therapeutics (HRTX)
(Delayed Data from NSDQ)
$2.55 USD
-0.10 (-3.77%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $2.56 +0.01 (0.39%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/07/2024
Time: BMO |
3/2024 | $-0.08 | -17.39% |
Earnings Summary
For their last quarter, Heron Therapeutics (HRTX) reported earnings of -$0.07 per share, beating the Zacks Consensus Estimate of $-0.15 per share. This reflects a positive earnings surprise of 53.33%. Look out for HRTX's next earnings release on May 07, 2024. For the next earning release, we expect the company to report earnings of -$0.08 per share, reflecting a year-over-year increase of 70.37%.
Earnings History
Price & Consensus
Zacks News for HRTX
Oncternal Therapeutics (ONCT) Reports Q4 Loss, Tops Revenue Estimates
HRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services